ArticleAntimicrobial agents and chemotherapy2023

Impact of acquired broad-spectrum β-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam β-lactamase inhibitors in

Christophe Le Terrier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.